Skip to main content
. Author manuscript; available in PMC: 2020 Nov 20.
Published in final edited form as: Vaccine. 2020 Oct 22;38(49):7756–7763. doi: 10.1016/j.vaccine.2020.10.045

Figure 1. Pre-vaccine vs. post-vaccine pneumococcal prevalence of non-vaccine types for children under 5 in Israel, November 2009-July 2016.

Figure 1.

The observed log-prevalence of pneumococcus for each serotype is shown at Year 0 and Year 6, separately for Jewish and Bedouin children. If a serotype increased from or decreased to 0, the log prevalence is shown as “not detected” at the bottom of the graph.